During the past decade, Johann Wolfgang Goethe-University Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Johann Wolfgang Goethe-University Hospital" #1 sponsor was "Johann Wolfgang Goethe University Hospital" with 12 trials, followed by "Vertex Pharmaceuticals Incorporated" with 3 trials sponsored, "A. M. Zeiher" with 1 trials sponsored, "Birgit Assmus" with 1 trials sponsored and "Christoph Stephan" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Johann Wolfgang Goethe-University Hospital" #1 collaborator was "Blutspendedienst Baden-Württemberg - Hessen" with 1 trials as a collaborator, "Community Programs for Clinical Research on AIDS" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Guidant Corporation" with 1 trials as a collaborator and "Johann Wolfgang Goethe University Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Johann Wolfgang Goethe-University Hospital" are "Cystic Fibrosis" (3 trials), "Hepatitis C" (2 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Allergy" (1 trials) and "Asthma" (1 trials). Many other conditions were trialed in "Johann Wolfgang Goethe-University Hospital" in a lesser frequency.

Most popular intervention types in "Johann Wolfgang Goethe-University Hospital" are "Drug" (6 trials), "Other" (3 trials), "Procedure" (3 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "IVA" (3 trials), "Methacholine challenge testing" (2 trials), "VX-659/TEZ/IVA" (2 trials), "BEZ235" (1 trials) and "Intracoronary infusion of enriched bone marrow-derived progenitor cells" (1 trials). Other intervention names were less common.

The vast majority of trials in "Johann Wolfgang Goethe-University Hospital" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Johann Wolfgang Goethe-University Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Johann Wolfgang Goethe-University Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Johann Wolfgang Goethe-University Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".